Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells)

Biochemical Pharmacology

Volumn 73, Issue 9, 2007, Pages 1446-1454

  Cao, Guihua ^a   Gardner, Alice ^a   Westfall, Thomas C ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Apomorphine; Dopamine agonists; Dopamine receptors; Neuropeptide Y; PC12 cells; Radioimmunoassay

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; APOMORPHINE; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CHELERYTHRINE; CLOZAPINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; ETICLOPRIDE; FORSKOLIN; NEUROPEPTIDE Y; NIFEDIPINE; OMEGA CONOTOXIN GVIA; PHORBOL 13 ACETATE 12 MYRISTATE; PROPYLNORAPOMORPHINE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CHANNEL GATING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG INHIBITION; ENZYME INACTIVATION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ADENYLATE CYCLASE; ADRENAL GLAND NEOPLASMS; ANIMALS; APOMORPHINE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNELS; CATTLE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; NEUROPEPTIDE Y; PC12 CELLS; PERTUSSIS TOXIN; PHEOCHROMOCYTOMA; PROTEIN KINASE C; RABBITS; RATS;

EID: 33947385855     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.01.003     Document Type: Article

References (63)

1. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79 (1982) 5485-5489
2. Walter P., Grouzmann E., Burnier M., and Waeber B. The role of neuropeptide Y in cardiovascular regulation. Trends Pharmacol Sci 12 (1991) 111-115
3. Michel M.C., and Rascher W. Neuropeptide Y: a possible role in hypertension?. J Hyperten 13 (1995) 385-395
4. Flood J.F., Hernandez E.N., and Morley J.E. Modulation of memory processing by neuropeptide Y. Brain Res 421 (1987) 280-290
5. Floor J.F., Baker M.L., Hernandez E.N., and Morley J.E. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res 503 1 (1989) 73-82
6. Kaira S.P., Dube M.G., Foumier A., and Kaira P.S. Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol Behav 50 (1991) 5-9
7. Kaira S.P., Dube M.G., Sahu A., Phelps C.P., and Kaira P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88 (1991) 10931-10935
8. Obuchowicz E., and Turchan J. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat. Eur Neuropsychopharm 9 1/2 (1999) 51-59
9. Obuchowicz E. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus. Neuropeptides 30 5 (1996) 471-478
10. Smialowska M., Bajkowska M., Heilig M., Obuchowicz E., Turchan J., Maj M., and Przewlocki R. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala. Neuropeptides 35 2 (2001) 82-91
11. Gruber S.H., and Mathe A.A. Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum. J Neurosci Res 61 4 (2000) 458-563
12. Obuchowicz E., and Turchan J. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum. Neuropeptides 32 5 (1998) 473-480
13. Kerkerian L., Salin P., and Nieoullon A. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Neuroscience 26 (1988) 809-817
14. Lindefors N., Brene S., Herrera-Marschitz M., and Persson H. Regulation of neuropeptide Y gene expression in rat brain. Ann NY Acad Sci 611 (1990) 175-185
15. Cao G.H., Houston D., and Westfall T.C. Mechanism underlying dopamine receptor mediated inhibition of neuropeptide Y release from pheochromocytoma cells. Soc Neurosci Abs 21 (1995) 1378
16. 2 receptor-mediated inhibition of neuropeptideY (NPY) release from pheochromocytoma (PC12) cells. Physiologist 38 5 (1995) A260
17. DiMaggio D.A., Farah Jr. J.M., and Westfall T.C. The effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells. Endocrine 134 (1995) 719-727
18. Chen X, DiMaggio D, Han SP, Westfall TC. Autoreceptor-induced inhibition of neuropeptide Y release from PC12 cells is mediated by Y2 receptors. Am J Physiol 1997;273(Heart Circ Physiol 42):H1737-44
19. Chen X, Westfall TC. Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC-12 cells. Am J Physiol 1994;266(Cell Physiol 35):C784-93.
20. McCullough L.A., and Westfall T.C. Neuropeptide Y inhibits depolarization stimulated catecholamine synthesis in rat pheochromocytoma cells. Eur J Pharmacol 287 (1995) 271-277
21. 2+ channels and protein kinases. J Neurochem 67 (1996) 1090-1099
22. McCullough LA, Egan TM, Westfall TC. Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells. Am J Physiol 1998;274(Cell Physiol 43):C1290-7.
23. McCullough L.A., Egan T.M., and Westfall T.C. Neuropeptide Y receptors involved in calcium channel regulation in PC 12 cells. Regul Peptide 95/96 (1998) 1010-1107
24. DiMaggio DA. Neuropeptide Y function in sympathoadrenomedullary models. Ph.D. Thesis 1992; Saint Louis University.
25. Pugsley T.A., et al. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J Pharm Exp Ther 275 3 (1995) 1355-1413
26. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacol 32 (1993) 1075-1088
27. 2+ channels in rat pheochromocytoma cell lines. J Physiol (Lond) 426 (1990) 95-116
28. 2+ currents by protein kinase C activators and phosphatase inhibitors in nerve-growth-factor-differentiated rat pheochromocytoma (PC 12) cells. Pflugers Arch European J Phys 427 (1994) 510-516
29. Lledo P.M., Legendre P., Israel J.M., and Vincent J.D. Dopamine inhibits two characterized voltage dependent calcium currents in identified rat lactotroph cells. Endocrinol 127 (1990) 990-1001
30. 2 dopaminergic receptor activation in rat lactotroph cells. J Biol Chem 263 (1988) 10127-10134
31. Enjalbert A., Musset F., Chenard C., Priam M., Kordon C., and Heisler S. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist BAY-K-8644 through a pertussis toxin sensitive G-protein in anterior pituitary cells. Endocrinology 123 (1988) 406-412
32. 2 (short) dopamine receptors expressed in differentiated NG108-15 cells. Br J Pharmacol 111 (1994) 1061-1066
33. 2+currents in rat anterior pituitary cells. Neuron 8 (1992) 455-463
34. Cote T.E., Grewe C.W., Tsuruta K., Stoof J.C., Eskay R.L., and Kebabian J.W. D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5′-triphosphate. Endocrinology 110 (1982) 812-819
35. 2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 23 (1983) 576-584
36. 2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices. Eur J Pharmacol 136 (1987) 263-264
37. Canonico P.L., Valdenegro C.A., and MacLeod R.M. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine. Endocrinol 113 (1983) 7-14
38. 2 dopamine receptors in dissociated bovine anterior pituitary cells. Neurosci Lett 60 (1985) 267-272
39. Lledo P.M., Legendre P., Zhang J., Israel J.M., and Vincent J.D. Effects of dopamine on voltage-dependent potassium currents in identified rat lactotroph cells. Neuroendocrinology 52 (1990) 545-555
40. 2 receptor stimulation differentially affects voltage-activated calcium currents in rat pituitary melanotropic cell. J Physiol 450 (1992) 409-435
41. Sontag J.M., Sanderson P., Klepper M., Aunis D., Takeda K., and Bader M.-F. Modulation of secretion by dopamine involves decreases in calcium and nicotinic currents in bovine chromaffin cells. J Physiol 427 (1990) 495-517
42. 2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J Pharm Exp Ther 252 (1990) 586-592
43. Braun A.P., and Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol 57 (1995) 417-445
44. Langer S.Z. Twenty-five years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18 (1997) 95-99
45. Allgaier C., Kugelgen O.V., and Hertting G. Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator or protein kinase C. Eur J Pharmacol 129 (1986) 389-392
46. Haass H., Richard G., Brenn T., Schomig E., and Schomig A. Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart: role of calcium channels and protein kinase C. Naunyn-Schmiedebergs Arch Pharmacol 344 (1991) 527-531
47. Shuntoh H., and Tanaka C. Activation of protein kinase C potentiates norepinephrine release from sinus node. Am J Physiol 251 (1986) C833-C840
48. 2+/calmodulin-dependent protein kinase. J Biol Chem 267 (1992) 12197-12201
49. Cahill A.L., Horwitz J., and Perlman R.L. Phosphorylation of tyrosine hydroxylase in protein kinase C deficient PC 12 cells. Neuroscience 30 (1989) 811-881
50. Baizer L., and Weiner N. Regulation of dopamine release from PC 12 pheochromocytoma cell culture during stimulation with elevated potassium or carbachol. J Neurochem 44 (1985) 495-501
51. 2+-channels in two secretory cell lines, PC12 and RIMm5F. J Biol Chem 261 (1986) 32-35
52. Harris K.M., Kongsamut S., and Miller R.J. Protein kinase C mediated regulation of calcium channels in PC12 pheochromocytoma cells. Biochem Biophys Res Comm 134 (1986) 1049-1056
53. Messing R.C., Carpentier C.L., and Greenberg D.A. Inhibition of calcium influx and calcium channel antagonist binding in the PC12 neural line by phorbol esters and protein kinase C. Biochem Biophys Res Comm 136 (1986) 1049-1056
54. Delbeke D., Scammell J.G., Martinez-Campos A., and Dannies P.S. Dopamine inhibits prolactin release when cyclic adenosine 3′,5′-monophosphate levels are elevated. Endocrinology 118 (1986) 1271-1277
55. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350 (1991) 610-614
56. Banihashemi B., and Albert P.R. Dopamine-D2S receptor inhibition of calcium influx, adenylate cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Gα and Gβγ requirements. Mol Endocrinol 16 10 (2002) 2393-2404
57. 2+ channels by protein kinase C in rat central and peripheral neurons: disruption of G-protein-mediated inhibition. Neuron 11 2 (1993) 305-320
58. s-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J Biol Chem 274 14 (1999) 9238-9245
59. Albert P.R., Neve K.A., Bunzow J.R., and Civelli O. Coupling on a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J Biol Chem 16 10 (1990) 2393-2404
60. Mei Y.A. High-voltage-activated calcium current and its modulation by dopamine D4 and pituitary adenylate cyclase activating polypeptide receptors in cerebellar granule cells. Zhongguo Yao Li Xue Bao 20 1 (1999) 3-9
61. 2+ accumulation when dopamine receptors are activated in striatal neurons. Brain Res Mol Brain Res 131 1/2 (2004) 65-72
62. Montmayeur J.P., and Borrelli E. Tanscription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci USA 88 (1991) 3135-3139
63. Montmayeur J.P., Guiramand J., and Borrelli E. Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 7 2 (1993) 161-170